ADYX Adynxx Inc

USD 0.00 0.00 0
Icon

Adynxx Inc (ADYX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.0001

0.00 (0.00)%

USD 871.00

N/A

N/A

N/A

Icon

ADYX

Adynxx Inc (USD)
COMMON STOCK | OTC
USD 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 871.00

N/A

USD 0.00

Adynxx Inc (ADYX) Stock Forecast

N/A

Based on the Adynxx Inc stock forecast from 0 analysts, the average analyst target price for Adynxx Inc is not available over the next 12 months. Adynxx Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Adynxx Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Adynxx Inc’s stock price was USD 0.0001. Adynxx Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Adynxx Inc
No recent average analyst rating found for Adynxx Inc

Company Overview Adynxx Inc

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, inc...Read More

https://www.adynxx.com

100 Pine Street, San Francisco, CA, United States, 94111

6

December

USD

USA

Adjusted Closing Price for Adynxx Inc (ADYX)

Loading...

Unadjusted Closing Price for Adynxx Inc (ADYX)

Loading...

Share Trading Volume for Adynxx Inc Shares

Loading...

Compare Performance of Adynxx Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ADYX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Adynxx Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -3.06 (-0.76%) USD107.38B 29.93 21.06

ETFs Containing ADYX

Symbol Name ADYX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Adynxx Inc (ADYX) Stock

Stock Target Advisor's fundamental analysis for Adynxx Inc's stock is Very Bearish.

Unfortunately we do not have enough data on ADYX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ADYX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ADYX's stock to indicate if its overvalued.

The last closing price of ADYX's stock was USD 0.00.

The most recent market capitalization for ADYX is USD 871.00.

Unfortunately we do not have enough analyst data on ADYX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Adynxx Inc's stock.

As per our most recent records Adynxx Inc has 6 Employees.

Adynxx Inc's registered address is 100 Pine Street, San Francisco, CA, United States, 94111. You can get more information about it from Adynxx Inc's website at https://www.adynxx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...